Analyzing the trends and forecasting Global Infectious Disease Therap Global Infectious Disease Therapeutics Market | Page 3

 Antifungal
 Antiviral
 Antiparasite
 Others
3) By Infection type
 Bacterial
 Viral
 Fungal
 Parasitic
 Others
4) By Distribution Channels
 Hospitals
 Clinics
 Others
Based on Geography, the Infectious disease therapeutics market is analyzed under various
regions namely North America, Europe, Asia-Pacific, Latin America, and the Middle East and
Africa. North America is expected to account the highest share in the market followed by
Asia-Pacific and Europe owing to rising incidence of infectious diseases, and increasing aging
population. Asia-Pacific is projected to account the highest CAGR over the forecast period
owing to increasing government funding in some emerging countries such as India, China.





North America Infectious Disease Therapeutics Market
Europe Infectious Disease Therapeutics Market
Asia-Pacific Infectious Disease Therapeutics Market
Latin America Infectious Disease Therapeutics Market
Middle East and Africa Infectious Disease Therapeutics Market
Request Discount: http://www.marketdataforecast.com/market-reports/global-infectious-
Disease-therapeutics-market-1320/request-discount
Some of the major companies operating in global Infectious disease Therapeutics Market F.
Hoffmann-La Roche, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Pfizer,
Achillion Pharmaceuticals, Novartis, AbbVie, Astellas Pharma, AstraZeneca, Auritec Pharmaceuticals,
Bayer, Bristol-Myers Squibb, Chimerix Pharmaceuticals, Cubist, Eli Lilly, Isis Pharmaceuticals,
Mitsubishi Tanabe Pharma, pSivida, Sanofi.